Transcriptional modulation of human endogenous retroviruses in primary CD4+ T cells following vorinostat treatment

Cory H. White, Nadejda Beliakova-Bethell, Steven M. Lada, Michael S. Breen, Tara P. Hurst, Celsa A. Spina, Douglas D. Richman, John Frater, Gkikas Magiorkinis, Christopher H. Woelk*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    25 Citations (SciVal)
    Original languageEnglish
    Article number603
    JournalFrontiers in Immunology
    Volume9
    Issue numberAPR
    DOIs
    Publication statusPublished (VoR) - 12 Apr 2018

    Funding

    We acknowledge support from the IRIDIS 4 High Performance Computing Facility and associated support services at the University of Southampton, the Collaboratory of AIDS Researchers for Eradication (CARE), the Bioinformatics Core at the University of Southampton, and the Genomics and Sequencing Core at the UCSD Center for AIDS Research. This work was performed with the support of the UCSD Center for AIDS Research from the National Institutes of Health (NIH) to DR (P30 AI36214); the U.S. Department of Veterans Affairs grant (K2BX002731) to NBB; the James B. Pendleton Charitable Trust; as well as other NIH grants to DR (the CARE Martin Delaney Collaboratory U19 AI096113) and to CWo (AI104282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

    Keywords

    • Histone deacetylase inhibitor
    • Human endogenous retroviruses
    • Long terminal repeat
    • Primary CD4 T cells
    • Total RNA-Seq

    Fingerprint

    Dive into the research topics of 'Transcriptional modulation of human endogenous retroviruses in primary CD4+ T cells following vorinostat treatment'. Together they form a unique fingerprint.

    Cite this